Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"HER2+ breast cancer"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Jain%2C+Esha%22&type=Person&filter%5B%5D=topic_facet%3A%22HER2%2B+breast+cancer%22
/vufind/Search/Results?lookfor=%22Jain%2C+Esha%22&type=Person&filter%5B%5D=topic_facet%3A%22HER2%2B+breast+cancer%22
Search /vufind/Search2/Results?lookfor=%22Jain%2C+Esha%22&type=Person&filter%5B%5D=topic_facet%3A%22HER2%2B+breast+cancer%22
PubPharm (4)
1
A phase II study of efficacy, toxicity, and the potential impact of genomic alterations on response to eribulin mesylate in combination with trastuzumab and pertuzumab in women with human epidermal growth factor receptor 2 (HER2)+ metastatic breast cancer
enthalten in:
Breast cancer research and treatment
| 2021
von
Balch, S.
|
Vaz-Luis, I.
|
Li, T.
| +11
Wird geladen...
2
A phase II study of efficacy, toxicity, and the potential impact of genomic alterations on response to eribulin mesylate in combination with trastuzumab and pertuzumab in women with human epidermal growth factor receptor 2 (HER2)+ metastatic breast cancer
enthalten in:
Breast cancer research and treatment
| 2021
von
Balch, S.
|
Vaz-Luis, I.
|
Li, T.
| +11
Wird geladen...
3
A phase II study of efficacy, toxicity, and the potential impact of genomic alterations on response to eribulin mesylate in combination with trastuzumab and pertuzumab in women with human epidermal growth factor receptor 2 (HER2)+ metastatic breast cancer
enthalten in:
Breast cancer research and treatment
| 2021
von
Balch, S.
|
Vaz-Luis, I.
|
Li, T.
| +11
Wird geladen...
4
A phase II study of efficacy, toxicity, and the potential impact of genomic alterations on response to eribulin mesylate in combination with trastuzumab and pertuzumab in women with human epidermal growth factor receptor 2 (HER2)+ metastatic breast cancer
enthalten in:
Breast cancer research and treatment
| 2021
von
Balch, S.
|
Vaz-Luis, I.
|
Li, T.
| +11
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: HER2+ breast cancer
Medienart
4
Aufsätze
3
E-Artikel
3
E-Ressourcen
1
Gedruckte Aufsätze
Zeitschriftentitel
4
Breast cancer research and treatment
Thema
4
Eribulin mesylate
HER2+ breast cancer
4
Pertuzumab
4
Trastuzumab
1
Antibodies, Monoclonal, Humanized
1
Clinical Trial, Phase II
1
EC 2.7.10.1
1
ERBB2 protein, human
1
Furans
1
Journal Article
1
K16AIQ8CTM
1
Ketones
1
LR24G6354G
1
P188ANX8CK
1
Receptor, ErbB-2
1
eribulin
1
pertuzumab
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
Erscheinungsjahr(e)
Von:
Bis:
Sprache
4
Englisch
Haven't found what you're looking for?
Wird geladen...